Photo: Antonius Ferret
A dental checkup usually starts with a form asking about medications, and it's easy to treat that question as a formality – the kind of box everyone checks without thinking much about why it's there. It's not a formality. A meaningful share of the medications people take for entirely unrelated reasons can change how vulnerable their teeth are to decay, and a dentist who doesn't know about them is working from an incomplete picture of the actual risk.
Two related terms that aren't quite the same thing:
The everyday phrase for this is dry mouth, and clinically it splits into two related but distinct concepts. Xerostomia is the subjective sensation of dryness – how a mouth feels to the person experiencing it. Hyposalivation is the measurable, reduced rate of actual saliva production. The two usually occur together, but not always; someone can feel persistently dry without a measurable drop in output, or have reduced flow without feeling much different day to day. Hyposalivation directly weakens the mouth's natural defenses. Xerostomia can be an important warning sign that deserves investigation, even when testing doesn't reveal a substantial reduction in salivary flow.
Saliva buffers the acid that forms after eating, washes away food particles, and delivers minerals that continuously re-harden enamel throughout the day – a natural cycle of demineralization and remineralization that repeats many times over the course of a day without anyone noticing it happening.
Reduce saliva's volume or buffering capacity enough, and that reset stops keeping pace, which means a normal brushing routine that used to be sufficient can quietly stop being enough.
Why this shows up more in older adults, and why the reason matters:
Persistent dry mouth becomes noticeably more common with age, and it's tempting to file that under normal aging and move on. The National Institute of Dental and Craniofacial Research says that framing is wrong: dry mouth isn't a normal part of getting older. Much of the apparent age correlation reflects medication use and associated health conditions rather than aging alone.
That distinction matters practically, because it means the fix generally isn't "there's nothing to be done, it's just aging." It's identifying which specific medication or condition is responsible and adjusting the oral-care plan around that specific cause.
The medication categories a dentist actually needs to know about:
A long list of common prescriptions can reduce saliva production as a side effect: antihistamines, several blood pressure medications, many antidepressants, and a range of others most people wouldn't think to connect to their teeth at all. Diuretics and several other blood-pressure medications are associated with dry-mouth symptoms or reduced salivary function.
Certain antidepressants and anti-anxiety medications have anticholinergic effects that can reduce glandular secretion, saliva included. Even something as routine as a long-term allergy medication, taken daily for months or years without much thought, can gradually shift someone's baseline cavity risk without anyone connecting the two. None of these get flagged automatically at a dental visit unless the patient mentions them, because a general medication list handed to a physician doesn't automatically make its way to a separate dentist's office.
Route of administration can matter too, although the evidence is medication-specific. The clearest documented example is transmucosal buprenorphine, which is designed to dissolve under the tongue or against the inside of the cheek. Researchers have proposed acidity, repeated oral exposure, and changes in salivary function as possible explanations for the associated dental problems, but the precise mechanism remains unsettled.
Buprenorphine as the clearest case study:
The affected category includes Suboxone and similar products used for opioid use disorder, as well as a buccal buprenorphine product approved for pain. The FDA issued a drug safety communication in January 2022 after identifying 305 reported cases between buprenorphine's 2002 approval and the end of 2018, describing dental problems including tooth decay, cavities, oral infections, and, in more serious cases, tooth loss – occurring even in patients with no prior history of dental issues. Because these were reported cases rather than a controlled incidence study, the total does not show how likely an individual patient is to experience dental problems.
The FDA was explicit that this warning doesn't change buprenorphine's underlying value as a treatment. Patients are specifically advised to continue taking it as prescribed rather than stopping suddenly, since doing so can cause withdrawal or a return to opioid misuse – outcomes far more serious than the dental risk the warning describes.
The point of the communication was to get the risk documented and communicated, not to discourage a treatment the FDA itself calls clearly beneficial on balance. The FDA also directed the update toward prescribing information and patient medication guides specifically, so that going forward, the risk gets disclosed as a standard part of starting treatment rather than something a patient has to encounter secondhand or after the fact.
What to actually do with a dissolving medication:
The FDA's recommendations are specific enough to follow exactly, and most patients on this kind of medication have never heard them:
- Let the medication dissolve completely before doing anything else.
- Take a large sip of water and swish it gently around the teeth and gums.
- Swallow the water rather than spitting it out.
Wait at least one hour before brushing – brushing too soon after can actually cause more damage to enamel that's been temporarily softened, rather than protecting it.
Tell a dentist about the medication specifically, ideally before starting it or as soon as possible afterward, so a baseline evaluation and a tailored prevention plan can be set up in advance rather than after a problem shows up.
More broadly, for anyone dealing with chronic dry mouth from any cause, the American Dental Association notes that sugar-free gum can stimulate remaining salivary function and that alcohol-containing mouthrinses should be avoided because they can aggravate dryness. Depending on the patient's cavity risk, a dentist may also recommend prescription-strength fluoride or more frequent monitoring, rather than assuming the standard twice-a-year visit and over-the-counter toothpaste covers it.
What the FDA Warning Does and Doesn’t Establish
A separate, ongoing legal question is worth distinguishing clearly from the medical one described above. Pending lawsuits allege that manufacturers failed to warn of potential dental injuries they already knew about before the FDA required updated labeling – that's the plaintiffs' allegation, not an established finding of fault. The FDA's own communication documents the dental risk and what patients should do about it; it doesn't itself resolve what any specific manufacturer knew or when.
Summary...
The practical takeaway sits apart from that legal question entirely: a medication list handed to a dentist, updated accurately and completely, is one of the simplest things a patient controls that can meaningfully change how a very ordinary-seeming risk gets caught early instead of showing up as a surprise a year or two later.
It costs nothing beyond a few extra minutes at an intake appointment, and it's the one step in this entire picture that doesn't depend on a manufacturer, a regulator, or a lawsuit resolving anything at all – just on whether the person filling out that form treats the medication question as worth answering completely.
